Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,907 | 16 | 87.0% |
| Travel and Lodging | $2,103 | 4 | 8.4% |
| Food and Beverage | $1,161 | 22 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $18,700 | 25 | $0 (2022) |
| Genentech USA, Inc. | $3,710 | 6 | $0 (2021) |
| ROCHE MOLECULAR SYSTEMS, INC. | $2,400 | 2 | $0 (2024) |
| Roche Diagnostics Corporation | $123.43 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $105.24 | 1 | $0 (2024) |
| Amgen Inc. | $60.53 | 3 | $0 (2018) |
| Sanofi Pasteur Inc. | $21.41 | 1 | $0 (2018) |
| Cranial Technologies, Inc | $18.93 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $16.69 | 1 | $0 (2018) |
| PFIZER INC. | $15.04 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,629 | 4 | ROCHE MOLECULAR SYSTEMS, INC. ($2,400) |
| 2022 | $5,758 | 11 | ACADIA Pharmaceuticals Inc ($5,758) |
| 2021 | $820.00 | 1 | Genentech USA, Inc. ($820.00) |
| 2020 | $4,250 | 2 | ACADIA Pharmaceuticals Inc ($4,250) |
| 2019 | $6,343 | 8 | ACADIA Pharmaceuticals Inc ($3,452) |
| 2018 | $5,372 | 16 | ACADIA Pharmaceuticals Inc ($5,240) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2024 | ROCHE MOLECULAR SYSTEMS, INC. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 04/11/2024 | ROCHE MOLECULAR SYSTEMS, INC. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 03/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $105.24 | General |
| Category: Neuroscience | ||||||
| 02/15/2024 | Roche Diagnostics Corporation | — | Food and Beverage | In-kind items and services | $123.43 | General |
| Category: Diagnostics Information Solutions | ||||||
| 05/25/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/25/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/24/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/24/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | In-kind items and services | $462.96 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/24/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | In-kind items and services | $426.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/24/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $112.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/24/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | In-kind items and services | $61.75 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/24/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | In-kind items and services | $46.90 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/24/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $37.74 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/24/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | In-kind items and services | $37.47 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/24/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/14/2021 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $820.00 | General |
| 10/09/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/07/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/16/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $112.50 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/25/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $3,114.86 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/28/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $225.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/27/2019 | Genentech USA, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $187.42 | General |
| Category: None | ||||||
| 02/26/2019 | Genentech USA, Inc. | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: None | ||||||
| 02/26/2019 | Genentech USA, Inc. | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $752.36 | General |
| Category: None | ||||||
| 02/26/2019 | Genentech USA, Inc. | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $263.35 | General |
| Category: None | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 64 | 67 | $15,217 | $2,475 |
| 2021 | 15 | 736 | 1,391 | $200,872 | $68,260 |
| 2020 | 15 | 641 | 1,270 | $186,985 | $53,038 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 47 | $11,797 | $1,878 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $3,420 | $597.32 | 17.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 226 | 431 | $108,181 | $37,670 | 34.8% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 82 | 82 | $13,144 | $5,447 | 41.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 36 | 36 | $10,584 | $4,678 | 44.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 67 | 78 | $13,338 | $4,539 | 34.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 50 | $13,300 | $3,966 | 29.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 61 | $11,285 | $3,323 | 29.5% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 27 | 55 | $9,680 | $2,599 | 26.8% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 23 | 23 | $5,750 | $2,113 | 36.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 88 | 88 | $4,488 | $1,454 | 32.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 17 | 42 | $5,334 | $674.12 | 12.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 12 | 12 | $2,232 | $621.06 | 27.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 39 | 48 | $1,296 | $451.25 | 34.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 34 | 305 | $983.60 | $293.37 | 29.8% |
| 85610 | Blood test, clotting time | Office | 2021 | 14 | 68 | $748.00 | $291.72 | 39.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $528.00 | $139.08 | 26.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 248 | 463 | $116,213 | $30,724 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 33 | 33 | $9,702 | $3,763 | 38.8% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 15 | 15 | $8,631 | $3,452 | 40.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 32 | 77 | $12,760 | $3,065 | 24.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 60 | $10,260 | $2,952 | 28.8% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 41 | 41 | $6,253 | $2,501 | 40.0% |
| 77067 | Mammography of both breasts | Office | 2020 | 23 | 23 | $5,750 | $2,193 | 38.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $6,128 | $1,603 | 26.2% |
About Dr. Simon Sheard, D.O
Dr. Simon Sheard, D.O is a Family Medicine healthcare provider based in Tempe, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1083926877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simon Sheard, D.O has received a total of $25,172 in payments from pharmaceutical and medical device companies, with $2,629 received in 2024. These payments were reported across 42 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($21,907).
As a Medicare-enrolled provider, Sheard has provided services to 1,441 Medicare beneficiaries, totaling 2,728 services with total Medicare billing of $123,773. Data is available for 3 years (2020–2022), covering 32 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Tempe, AZ
- Active Since 07/08/2010
- Last Updated 04/17/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083926877
Products in Payments
- NUPLAZID (Drug) $18,700
- Non-Covered Product (Drug) $2,890
- SPRAVATO (Drug) $105.24
- Repatha (Biological) $44.22
- MENACTRA (Drug) $21.41
- Doc Band (Device) $18.93
- PREVNAR - 13 (Biological) $15.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tempe
Dr. Thomas Fiel, D.o, D.O
Family Medicine — Payments: $119,615
Alan Andresen, M.d, M.D
Family Medicine — Payments: $19,653
Dr. Rajiv Parikh, M.d, M.D
Family Medicine — Payments: $17,554
Dr. Enrique Cifuentes, Jr., Md, MD
Family Medicine — Payments: $14,448
Anne Marie Reed, Do, DO
Family Medicine — Payments: $13,025
Curtis Page, Md, MD
Family Medicine — Payments: $10,846